Trial intelligence / Profile preview

Prednisone and Solu-Medrol Effect on Exercise in COPD

NCT01978665Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Apr 2013
Primary completion
Dec 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of prednisone, methylprednisolone in chronic obstructive pulmonary disease (COPD), sponsored by Bispebjerg and Frederiksberg Hospital. Started Apr 2013; status: completed.

02

Drugs

prednisonemethylprednisolone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01978665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01978665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call